BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11080687)

  • 1. Inhibition of phospholipase A(2) as a therapeutic target.
    Yedgar S; Lichtenberg D; Schnitzer E
    Biochim Biophys Acta; 2000 Oct; 1488(1-2):182-7. PubMed ID: 11080687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of phospholipase A2 activities for the treatment of inflammatory conditions.
    Yedgar S; Cohen Y; Shoseyov D
    Biochim Biophys Acta; 2006 Nov; 1761(11):1373-82. PubMed ID: 16978919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, function, and regulation of group V phospholipase A(2).
    Cho W
    Biochim Biophys Acta; 2000 Oct; 1488(1-2):48-58. PubMed ID: 11080676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase A2 inhibitors as potential anti-inflammatory agents.
    Meyer MC; Rastogi P; Beckett CS; McHowat J
    Curr Pharm Des; 2005; 11(10):1301-12. PubMed ID: 15853686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular components that functionally interact with signaling phospholipase A(2)s.
    Murakami M; Nakatani Y; Kuwata H; Kudo I
    Biochim Biophys Acta; 2000 Oct; 1488(1-2):159-66. PubMed ID: 11080685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipase A(2)s in cell injury and death.
    Cummings BS; McHowat J; Schnellmann RG
    J Pharmacol Exp Ther; 2000 Sep; 294(3):793-9. PubMed ID: 10945826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time cell assays of phospholipase A(2)s using fluorogenic phospholipids.
    Manna D; Cho W
    Methods Enzymol; 2007; 434():15-27. PubMed ID: 17954240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cell membrane and phospholipids].
    Chap H; Douste-Blazy L
    Arch Mal Coeur Vaiss; 1985 Dec; 78 Spec No():13-9. PubMed ID: 3938939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s.
    Kita Y; Ohto T; Uozumi N; Shimizu T
    Biochim Biophys Acta; 2006 Nov; 1761(11):1317-22. PubMed ID: 16962823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes.
    Triggiani M; Granata F; Giannattasio G; Marone G
    J Allergy Clin Immunol; 2005 Nov; 116(5):1000-6. PubMed ID: 16275367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase A(2)s and lipid peroxidation.
    Nigam S; Schewe T
    Biochim Biophys Acta; 2000 Oct; 1488(1-2):167-81. PubMed ID: 11080686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2.
    Strokin M; Chechneva O; Reymann KG; Reiser G
    Neuroscience; 2006 Jun; 140(2):547-53. PubMed ID: 16563639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-phospholipid interactions in secretory cells: a new perspective on stimulus-secretion coupling.
    Rubin RP
    Fed Proc; 1982 Apr; 41(6):2181-7. PubMed ID: 6281077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase A(2).
    Diaz BL; Arm JP
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):87-97. PubMed ID: 12895591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-lipoic acid: an inhibitor of secretory phospholipase A2 with anti-inflammatory activity.
    Jameel NM; Shekhar MA; Vishwanath BS
    Life Sci; 2006 Dec; 80(2):146-53. PubMed ID: 17011589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PhospholipaseA2: a key regulator of inflammatory signalling and a connector to fibrosis development in atherosclerosis.
    Oestvang J; Johansen B
    Biochim Biophys Acta; 2006 Nov; 1761(11):1309-16. PubMed ID: 16904370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naegleria fowleri amoebae express a membrane-associated calcium-independent phospholipase A(2).
    Barbour SE; Marciano-Cabral F
    Biochim Biophys Acta; 2001 Feb; 1530(2-3):123-33. PubMed ID: 11239815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction.
    Neidlinger NA; Larkin SK; Bhagat A; Victorino GP; Kuypers FA
    J Biol Chem; 2006 Jan; 281(2):775-81. PubMed ID: 16278219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory phospholipases A2 as multivalent mediators of inflammatory and allergic disorders.
    Granata F; Balestrieri B; Petraroli A; Giannattasio G; Marone G; Triggiani M
    Int Arch Allergy Immunol; 2003 Jul; 131(3):153-63. PubMed ID: 12876405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7.
    Leslie CC; Voelker DR; Channon JY; Wall MM; Zelarney PT
    Biochim Biophys Acta; 1988 Dec; 963(3):476-92. PubMed ID: 3143418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.